L. S. Turner

Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.

A. Bielawska, Y. Hannun, Joseph Cheng, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.

A. Bielawska, Y. Hannun, Jun Li, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials

S. Hoffman, J. Norris, Joseph C. Cheng, 2010, Expert opinion on therapeutic targets.

Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells

A. Bielawska, Y. Hannun, J. Bielawski, 2007, Cancer Chemotherapy and Pharmacology.